dichlorotetrakis(dimethyl sulfoxide)ruthenium ii has been researched along with Leukemia P388 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alessio, E; Boccarelli, A; Coluccia, M; Giordano, D; Loseto, F; Mestroni, G; Nassi, A; Sava, G | 1 |
1 other study(ies) available for dichlorotetrakis(dimethyl sulfoxide)ruthenium ii and Leukemia P388
Article | Year |
---|---|
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cisplatin; DNA, Neoplasm; Drug Resistance; Leukemia P388; Male; Mice; Mice, Inbred Strains; Organometallic Compounds; Ruthenium; Tumor Cells, Cultured | 1993 |